Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

21 November 2023

Global health warning as antibiotic-resistant bacteria threatens new crisis

In an article for Express, Isabelle Durso writes about the urgent need for pharmaceutical companies to develop new antibiotics amid growing antibiotic resistance (AMR). The article references the Foundation's work on AMR.

Direct links

Read the full article

Durso writes about the escalating threat of AMR and highlights criticism toward pharmaceutical companies for insufficient research into new antibiotic drugs. She discusses the danger posed by antibiotic-resistant bacteria and the global impact of AMR, especially on people living in low- and middle-income countries, which rely on pharmaceutical companies for medication.

She points out the Foundation's call for heightened research efforts, and references some of its work on AMR.

"The Access to Medicine Foundation, based in the Netherlands, has said that drug resistance is a major threat and has called for more research into new antibiotic drugs."

Cross-sector Research

Learn more about our work on AMR
Featured News

The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them?

21 November 2023
News

What steps are companies taking to help curb AMR by manufacturing responsibly?

22 August 2023

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved